We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Ingersoll Rand Acquires Scinomix, Strengthens Life Sciences Portfolio
Read MoreHide Full Article
Key Takeaways
IR acquired Scinomix to expand its automation workflow capabilities across life sciences end markets.
The deal adds labeling, barcode scanning, and lab equipment capping technologies to IR's portfolio.
Scinomix will be integrated into Ingersoll Rand's Precision and Science Technologies segment.
Ingersoll Rand Inc. (IR - Free Report) recently completed the acquisition of a leading automation workflow technology provider — Scinomix, Inc. The financial terms of the transaction were kept under wraps.
Ingersoll Rand’s shares were up 3.1% yesterday to eventually close the trading session at $82.21.
Headquartered in Earth City, MO, Scinomix specializes in manufacturing advanced technologies that facilitate streamlining automation workflows across several industries. The company’s products are used for labeling, barcode scanning, and capping lab equipment like vials, tubes and microplates.
Acquisition Rationale
The latest buyout is in sync with Ingersoll Rand’s policy of acquiring businesses to expand its market share and customer base. The inclusion of Scinomix’s expertise in automation technologies, coupled with its strong innovation capabilities, will enable Ingersoll Rand to boost its life sciences products portfolio. It will also help IR expand its presence in lucrative end markets like pharmaceutical, clinical, biotechnology, genetic testing laboratories and agricultural.
Scinomix will be incorporated into Ingersoll Rand’s Life Sciences platform under the Precision and Science Technologies segment. The segment is engaged in manufacturing products, including fluid management equipment, powder containment and aftermarket parts for medical, laboratory, pharmaceutical and biopharmaceutical production.
Zacks Rank, Price Performance and Estimate Revisions
Ingersoll Rand, with approximately $32.7 billion market capitalization, currently carries a Zacks Rank #4 (Sell). The company’s growth-based investments are pushing up costs with a corresponding negative effect on the bottom line. Also, a high debt level may increase its financial obligations in the quarters ahead. However, it is set to gain from a healthy demand environment and innovation capabilities.
Image Source: Zacks Investment Research
In the past year, the company’s shares have lost 7.8% against the industry’s growth of 9.6%.
The Zacks Consensus Estimate for its earnings is pegged at $3.29 for 2025, suggesting a decrease of 0.6% from the 60-day-ago figure.
Key Picks
Some better-ranked stocks from the same space are presented below.
In the past 60 days, the Zacks Consensus Estimate for DXP Enterprises’ 2025 earnings has increased 5.9%.
Nordson Corporation (NDSN - Free Report) presently has a Zacks Rank of 2. Nordson delivered a trailing four-quarter average earnings surprise of 2.2%. In the past 60 days, the Zacks Consensus Estimate for Nordson’s fiscal 2026 (ending October 2026) earnings has increased 2.3%.
Trimble Inc. (TRMB - Free Report) currently carries a Zacks Rank of 2. TRMB delivered a trailing four-quarter average earnings surprise of 7.4%. In the past 60 days, the Zacks Consensus Estimate for Trimble’s 2025 earnings has increased 3.3%.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Ingersoll Rand Acquires Scinomix, Strengthens Life Sciences Portfolio
Key Takeaways
Ingersoll Rand Inc. (IR - Free Report) recently completed the acquisition of a leading automation workflow technology provider — Scinomix, Inc. The financial terms of the transaction were kept under wraps.
Ingersoll Rand’s shares were up 3.1% yesterday to eventually close the trading session at $82.21.
Headquartered in Earth City, MO, Scinomix specializes in manufacturing advanced technologies that facilitate streamlining automation workflows across several industries. The company’s products are used for labeling, barcode scanning, and capping lab equipment like vials, tubes and microplates.
Acquisition Rationale
The latest buyout is in sync with Ingersoll Rand’s policy of acquiring businesses to expand its market share and customer base. The inclusion of Scinomix’s expertise in automation technologies, coupled with its strong innovation capabilities, will enable Ingersoll Rand to boost its life sciences products portfolio. It will also help IR expand its presence in lucrative end markets like pharmaceutical, clinical, biotechnology, genetic testing laboratories and agricultural.
Scinomix will be incorporated into Ingersoll Rand’s Life Sciences platform under the Precision and Science Technologies segment. The segment is engaged in manufacturing products, including fluid management equipment, powder containment and aftermarket parts for medical, laboratory, pharmaceutical and biopharmaceutical production.
Zacks Rank, Price Performance and Estimate Revisions
Ingersoll Rand, with approximately $32.7 billion market capitalization, currently carries a Zacks Rank #4 (Sell). The company’s growth-based investments are pushing up costs with a corresponding negative effect on the bottom line. Also, a high debt level may increase its financial obligations in the quarters ahead. However, it is set to gain from a healthy demand environment and innovation capabilities.
Image Source: Zacks Investment Research
In the past year, the company’s shares have lost 7.8% against the industry’s growth of 9.6%.
The Zacks Consensus Estimate for its earnings is pegged at $3.29 for 2025, suggesting a decrease of 0.6% from the 60-day-ago figure.
Key Picks
Some better-ranked stocks from the same space are presented below.
DXP Enterprises (DXPE - Free Report) carries a Zacks Rank of 2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
In the past 60 days, the Zacks Consensus Estimate for DXP Enterprises’ 2025 earnings has increased 5.9%.
Nordson Corporation (NDSN - Free Report) presently has a Zacks Rank of 2. Nordson delivered a trailing four-quarter average earnings surprise of 2.2%. In the past 60 days, the Zacks Consensus Estimate for Nordson’s fiscal 2026 (ending October 2026) earnings has increased 2.3%.
Trimble Inc. (TRMB - Free Report) currently carries a Zacks Rank of 2. TRMB delivered a trailing four-quarter average earnings surprise of 7.4%. In the past 60 days, the Zacks Consensus Estimate for Trimble’s 2025 earnings has increased 3.3%.